Evidence map›Paper›PMID 37731850›Full record

SynthesisFrontiers in neurology2023

A systematic review and meta-analysis of health utility values among patients with ischemic stroke.

Jiting Zhou, Qiran Wei, Hongfei Hu, Wei Liu, Xin Guan, Aixia Ma, Luying Wang

Abstract readSystematic Review
In one paragraph

Synthesis in Frontiers in neurology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Mapping the modified rankin scale (mRS) onto the assessment of quality of life (AQoL) utilities.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2025
    Trial
  2. Article
  3. Article
  4. Utility-weighted modified rankin scale scores in patients with ischemic stroke: a multicenter observational study.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2026
    Observational
  5. Measuring the health outcomes of Chinese ischemic stroke patients based on the data from a longitudinal multi-center study.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2025
    Observational
  6. Review
  7. Article
  8. Quality of life and quality-adjusted life years after stroke in Sierra Leone.International journal of stroke : official journal of the International Stroke Society · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jiting ZhouSchool of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, China.
Qiran WeiSchool of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, China.
Hongfei HuSchool of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, China.
Wei LiuSchool of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, China.
Xin GuanSchool of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, China.
Aixia MaSchool of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, China.
Luying WangSchool of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Ischemic stroke (IS) has a considerable impact on the health-related quality of life (HRQoL) of patients. A systematic review was conducted to summarize and synthesize the HRQoL reported from IS patients. Methods: An electronic search was performed in PubMed, Web of Science, ScienceDirect, Embase, and Cochrane Library databases from inception to February 2022 for studies measuring utility values in IS patients. Basic information about the studies, patient characteristics, measurement of the utility values, and utility values were extracted and summarized. Utility values were pooled according to the time of evaluation, and disease severity was classified with modified Rankin Scale (mRS) scores. The quality of the studies was assessed according to key criteria recommended by the National Institute for Health and Care Excellence. Results: A total of 39 studies comprising 30,853 participants were included in the study. Measured with EQ-5D-3L, the pooled utility values were 0.42 [95% confidential interval (CI): 0.13 to 0.71], 0.55 (95% CI: 0.43 to 0.68), 0.65 (95% CI: 0.52 to 0.78), 0.60 (95% CI: 0.43 to 0.78), and 0.67 (95% CI: 0.60 to 0.74) for patients diagnosed with IS within 1, 3, 6, 12, and 24 months or above among poststroke patients. Four studies reported utility values classified by mRS scores where synthesized estimates stratified by mRS scores ranged from 0.91 (95% CI: 0.85 to 0.97) for patients with an mRS score of 1 to-0.04 (95% CI:-0.18 to 0.11) for those with an mRS score of 5. As for the health dimension profiles, usual activity was the most impacted dimension, while self-care was the least impacted one. Conclusion: This study indicated that the utility values in IS patients kept increasing from stroke onset and became relatively stabilized at 6 months poststroke. Health utility values decreased significantly as mRS scores increased. These results facilitate economic evaluations in utility retrieval and selection. Further exploration was required regarding the factors that affect the HRQoL of IS patients.

Indexed as

EQ-5Dhealth-related quality of lifeischemic strokesystematic reviewutility value

Identifiers

PMID37731850
PMCPMC10507900

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.